Pot stocks have cost exchange-traded fund (ETF) holders 40 percent since Canadian legalization leading to a down-turn in sentiment from investors, new research says.

Horizons ETFs Management, the company behind one of the most popular cannabis ETFs in Canada, published its quarterly survey results of advisors and investors on Monday (January 21).

The survey shows the decline of cannabis stocks has caused losses taking an impact on the bullish sentiment for these securities.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

On the overall Canadian markets, the report indicates “advisor and investor bullishness has declined on nearly all asset classes heading into the new year.”

Steve Hawkins, president and CEO of Horizons ETFs, said the post-legalization correction had caused a “more reserved attitude” towards marijuana investing moving into 2019.

Horizons asks for input from advisors and investors of the public markets and shares the results on a primary way with bullish, bearish or neutral sentiment expression.

“Marijuana equities, as represented by the North American Marijuana Index, lost more than 40 [percent] after recreational legalization in Canada,” Horizons indicated in its report.

Horizons portfolio holds two cannabis ETFs, the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) and the Horizons Emerging Marijuana Growers Index ETF (NEO:HMJR)

According to the survey results, both advisors and investors of the public space have expressed a “steep loss of positive expectation” for the cannabis sector.

Only 31 percent of respondents indicated a positive or bullish outlook on pot stocks.

Despite the gloomy outlook, Hawkins expects the growth of the industry to continue as companies show financial stability.

“As more of these Cannabis-sector companies begin to demonstrate their fundamentals through financial reporting, there will be a solid footing for analysts upon which to base their expectations for the industry – ensuring a measured outlook on growth,” Hawkins said.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Despite sentiment slowing down, projections continue to show massive industry

Earlier in January Vivien Azer, managing director and senior research analyst specializing in the beverage, tobacco, and cannabis sectors for financial institution Cowen (NASDAQ:COWN), raised her outlook on the value of the space.

The analyst wrote she expects the US cannabis market to represent sales of US$80 billion by 2030.

Similarly, a new study from the Arcview Group and BDS Analytics projected the global recreational sales of cannabis will amount to US$16.9 billion in 2019.

Beyond 2019, the Arcview Group is calling for recreational cannabis sales only to hit US$31.3 billion in 2022.

Investor takeaway

While those surveyed for the Horizons report demonstrate a bleak outlook on pot stocks right now, long-term projections show substantial returns awaiting investors.

Many factors played into the decline of stocks across the board in the public space.

However, the cannabis space is suffering some hits as Canadian companies continue to deploy assets for the adult-use market and eagerly await the entrance of edibles in the country, scheduled later this year.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

One major cannabis analyst gave her top stock pick this week as industry attention continues to converge on the path ahead for the US market.

Also this week, the CEO of Aphria (NASDAQ:APHA,TSX:APHA) gave an update on a critical merger and spoke about who holds the edge in the US in terms of American and Canadian cannabis operators.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 First Quarter Earnings Conference Call on Friday, May 7, 2021 at 8:30 a.m. EDT. Cronos Group’s senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

A live audio webcast of the earnings call will be available on the Company’s website at https://ir.thecronosgroup.com/events-presentations . The webcast of the call will be archived for replay on the Company’s website.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

A report just released in early April confirms that the cannabis beverage sector is thriving. According to this report from industry stalwart, Marijuana Business Daily while sales for vapes, pre-rolls and flower were lackluster, cannabis beverages shined:

Keep reading... Show less

BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/clean-tech/

Keep reading... Show less